CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guilin Sanjin Pharmaceutical Co Ltd Company Snapshot
Guilin Sanjin Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guilin Sanjin Pharmaceutical Co Ltd with three other companies in this sector in China: Shanghai Kaibao Pharmaceutical Company Limited (2016 sales of 1.50 billion Chinese Renmimbi [US$227.39 million] of which 100% was Industrial), Jinhe Biotechnology Co Ltd (1.50 billion Chinese Renmimbi [US$227.11 million] of which 72% was Medical Feeds Additives), and Shandong Shanda Wit Science and Technology Co Ltd (1.54 billion Chinese Renmimbi [US$234.47 million] of which 57% was Medicines).

Sales Analysis. Guilin Sanjin Pharmaceutical Co Ltd reported sales of 1.53 billion Chinese Renmimbi (US$231.65 million) for the year ending December of 2016. This represents an increase of 11.2% versus 2015, when the company's sales were 1.37 billion Chinese Renmimbi. Sales of Other Operation saw an increase that was more than double the company's growth rate: sales were up 120.1% in 2016, from 30.57 million Chinese Renmimbi to 67.29 million Chinese Renmimbi. Not all segments of Guilin Sanjin Pharmaceutical Co Ltd experienced an increase in sales in 2016: sales of Commodity Circulation fell 0.1% to 30.05 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guilin Sanjin Pharmaceutical Co Ltd
  Stock Performance Chart for Guilin Sanjin Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): 17.60
(Figures in Chinese Renmimbi)
1 Week -0.5%   13 Weeks 1.1%  
4 Weeks 0.9%   52 Weeks -6.1%  
 
Guilin Sanjin Pharmaceutical Co Ltd Key Data:
  Ticker: 002275 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,525,209,926
(Year Ending Jan 2017).
Employees: 2,374
  Currency: Chinese Renmimbi Market Cap: 10,387,520,000
  Fiscal Yr Ends: December Shares Outstanding: 590,200,000
  Share Type: Gu Closely Held Shares: 467,505,427
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.